+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Sivextro"

Sivextro Oral- Drug Insight, 2019 - Product Thumbnail Image

Sivextro Oral- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Sivextro (tedizolid phosphate) is an antibiotic used to treat certain bacterial infections. It belongs to a class of antibiotics called oxazolidinones, which work by stopping the growth of bacteria. Sivextro is used to treat skin and soft tissue infections caused by certain bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). It is also used to treat pneumonia caused by certain bacteria. Sivextro is available in tablet and intravenous (IV) forms. Sivextro is marketed by Merck & Co., Inc. in the United States and by Shionogi & Co., Ltd. in Japan. It is also available in other countries through various generic manufacturers. The Sivextro market is a rapidly growing segment of the antibiotics market. It is used to treat a variety of bacterial infections, including skin and soft tissue infections and pneumonia. The increasing prevalence of antibiotic-resistant bacteria is driving the growth of the Sivextro market. Companies in the Sivextro market include Merck & Co., Inc., Shionogi & Co., Ltd., and various generic manufacturers. Show Less Read more